Beijing: China has reportedly approved patent for CanSino Biologics Inc’s COVID-19 vaccine — Ad5-nCOV. It is the first patent granted by China for a COVID-19 vaccine.
Saudi Arabia will be carrying out the Phase-III clinical trials for the CanSino vaccine this month.
CanSino is exploring testing the vaccine in Russia, Brazil and Chile as well. CanSino’s Hong Kong shares rose by around 14 per cent on Monday.
Also Read: First Batch Of Russian COVID-19 Vaccine To Roll Out This Month
Bhubaneswar: The death toll reportedly due to consumption of mango kernel gruel in Odisha’s Kandhamal…
Angul: Naveen Jindal, Hon'ble 3rd time Member of Parliament from Kurukshetra, Haryana, and Chairman of Jindal…
Mumbai: Ajay Devgn’s cop universe ‘Singham Again’ and Kartik Aaryan’s horror comedy ‘Bhool Bhulaiyaa 3’…
Bhubaneswar: The Odisha government will take steps to prevent untimely Rath Yatra anywhere in the…
New Delhi: Anmol Bishnoi, brother of jailed gangster Lawrence Bishnoi, was detained in the United States…
New Delhi/Bhubaneswar: While the 43rd India International Trade Fair (IIYF) enters its fifth day in…
Bhubaneswar: A team of AIIMS in Bhubaneswar saved the life of a young man, whose…
Mumbai: It's known to all that all is not well in Abhishek Bachchan and Aishwarya…